# NordicTrip, a Translational Study of Preoperative Chemotherapy in TNBC

Source: https://onco.cc/trials/nct04335669/  
OnCo record `nct04335669` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 3 trial of epirubicin, cyclophosphamide, paclitaxel / nab-paclitaxel, carboplatin and other drugs in triple-negative breast cancer, run by Lund University Hospital, active but no longer recruiting.

## Summary

NordicTrip, a Translational Study of Preoperative Chemotherapy in TNBC is a phase 3, randomised interventional study registered as NCT04335669 by Lund University Hospital, with a registry enrolment figure of 325 participants, started 2019-12-20 and due to reach its primary completion in 2035-09. Interventions recorded: epirubicin, cyclophosphamide, paclitaxel, carboplatin, pembrolizumab; epirubicin, cyclophosphamide, capecitabine, paclitaxel, carboplatin, pembrolizumab. Conditions listed: Breast Cancer; Triple Negative Breast Neoplasms. Sites: Denmark, Sweden. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: active
- Last checked: 2026-09-24
- Tags: ctgov-ingest; tnbc-deep-dive
- Registry id: NCT04335669
- Phase: 3
- Setting: A Translational Randomized Phase III Study Exploring the Effect of the Addition of Capecitabine to Carboplatine Based Chemotherapy in Early "Triple Negative" Breast Cancer
- Sponsor: Lund University Hospital
- Enrolled: 325

## Sources

- ClinicalTrials.gov NCT04335669: https://clinicaltrials.gov/study/NCT04335669

## Connected records

- cancers: [Early triple-negative breast cancer](https://onco.cc/cancers/tnbc-early/)
- technologies: [Cytotoxic chemotherapy](https://onco.cc/technologies/cytotoxic-chemotherapy/), [Immune checkpoint inhibitors](https://onco.cc/technologies/checkpoint-inhibitor/), [Platinum agents](https://onco.cc/technologies/platinum/)
- drugs: [Capecitabine](https://onco.cc/drugs/capecitabine/), [Carboplatin](https://onco.cc/drugs/carboplatin/), [Cyclophosphamide](https://onco.cc/drugs/cyclophosphamide/), [Epirubicin](https://onco.cc/drugs/epirubicin/), [Paclitaxel / nab-paclitaxel](https://onco.cc/drugs/paclitaxel/), [Pembrolizumab](https://onco.cc/drugs/pembrolizumab/)
- terms: [Triple-negative breast cancer trials open today (registry snapshot and UK sites)](https://onco.cc/terms/tnbc-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct04335669.json